|
|
Registro completo
|
Biblioteca (s) : |
INIA Las Brujas. |
Fecha : |
02/09/2019 |
Actualizado : |
02/09/2019 |
Tipo de producción científica : |
Presentaciones Orales |
Autor : |
BENÍTEZ GALEANO, M. J.; CASTELLS, M.; BERTALMIO, A.; RUBIO, L.; HERNÁNDEZ-RODRÍGUEZ, L.; MAESO, D.; RIVAS, F.; COLINA, R. |
Afiliación : |
MARÍA JOSÉ BENÍTEZ GALEANO, Laboratorio de Virología Molecular, Centro Universitario Regional Noroeste (CENUR Noroeste), Universidad de la República, Salto, Uruguay.; MATÍAS CASTELLS, Laboratorio de Virología Molecular, Centro Universitario Regional Noroeste (CENUR Noroeste), Universidad de la República, Salto, Uruguay.; ANA MARIA BERTALMIO CASARIEGO, INIA (Instituto Nacional de Investigación Agropecuaria), Uruguay; LETICIA PAOLA RUBIO CATTANI, INIA (Instituto Nacional de Investigación Agropecuaria), Uruguay; LESTER HERNÁNDEZ RODRÍGUEZ, INIA (Instituto Nacional de Investigación Agropecuaria), Uruguay.; DIEGO CESAR MAESO TOZZI, INIA (Instituto Nacional de Investigación Agropecuaria), Uruguay; CARLOS FERNANDO RIVAS GRELA, INIA (Instituto Nacional de Investigación Agropecuaria), Uruguay; RODNEY COLINA, Laboratorio de Virología Molecular, Centro Universitario Regional Noroeste (CENUR Noroeste), Universidad de la República, Salto, Uruguay. |
Título : |
Progress on Citrus tristeza virus research in Uruguay: unravelling the enemy from the inside. (SIII-O-7). [oral presentations]. |
Complemento del título : |
Session III: Pests and Diseases. |
Fecha de publicación : |
2018 |
Fuente / Imprenta : |
In: RIivas, F. (Ed.). IV International Symposium on Citrus Biotechnology. Book of Abstracts. Montevideo (UY): INIA. |
Páginas : |
p. 59. |
Serie : |
(INIA Serie Técnica; 244) |
ISBN : |
978-9974-38-396-8 |
ISSN : |
1688-9266 |
DOI : |
http://doi.org/10.35676/INIA/ST.244 |
Idioma : |
Inglés |
Contenido : |
Since its appearance two centuries ago, the disease known as tristeza, is considered the most devastating virus-related illness of the citrus industry worldwide. Citrus
tristeza virus (CTV), the causing agent of the disease, is transmitted by graft or by aphids. Here, we report the results of the biological, molecular and evolutionary full-genome characterization of the most relevant genotypes in the country. |
Palabras claves : |
CITRUS TRISTEZA VIRUS (CTV). |
Thesagro : |
CITRUS. |
Asunto categoría : |
H20 Enfermedades de las plantas |
URL : |
http://www.ainfo.inia.uy/digital/bitstream/item/13225/1/Bertalmio-SIII-0-7-st-244-Citrus-Symposium-2018.pdf
|
Marc : |
LEADER 01329nam a2200277 a 4500 001 1060121 005 2019-09-02 008 2018 bl uuuu u00u1 u #d 020 $a978-9974-38-396-8 022 $a1688-9266 024 7 $ahttp://doi.org/10.35676/INIA/ST.244$2DOI 100 1 $aBENÍTEZ GALEANO, M. J. 245 $aProgress on Citrus tristeza virus research in Uruguay$bunravelling the enemy from the inside. (SIII-O-7). [oral presentations]. 260 $aIn: RIivas, F. (Ed.). IV International Symposium on Citrus Biotechnology. Book of Abstracts. Montevideo (UY): INIA.$c2018 300 $ap. 59. 490 $a(INIA Serie Técnica; 244) 520 $aSince its appearance two centuries ago, the disease known as tristeza, is considered the most devastating virus-related illness of the citrus industry worldwide. Citrus tristeza virus (CTV), the causing agent of the disease, is transmitted by graft or by aphids. Here, we report the results of the biological, molecular and evolutionary full-genome characterization of the most relevant genotypes in the country. 650 $aCITRUS 653 $aCITRUS TRISTEZA VIRUS (CTV) 700 1 $aCASTELLS, M. 700 1 $aBERTALMIO, A. 700 1 $aRUBIO, L. 700 1 $aHERNÁNDEZ-RODRÍGUEZ, L. 700 1 $aMAESO, D. 700 1 $aRIVAS, F. 700 1 $aCOLINA, R.
Descargar
Esconder MarcPresentar Marc Completo |
Registro original : |
INIA Las Brujas (LB) |
|
Biblioteca
|
Identificación
|
Origen
|
Tipo / Formato
|
Clasificación
|
Cutter
|
Registro
|
Volumen
|
Estado
|
Volver
|
|
Registro completo
|
Biblioteca (s) : |
INIA Las Brujas. |
Fecha actual : |
19/04/2023 |
Actualizado : |
19/04/2023 |
Tipo de producción científica : |
Artículos en Revistas Indexadas Internacionales |
Circulación / Nivel : |
Internacional - -- |
Autor : |
BOK, M.; VEGA, C.G.; CASTELLS, M.; COLINA, R.; WIGDOROVITZ, A.; PARREÑO, V. |
Afiliación : |
MARINA BOK, INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires, 1686, Argentina; CONICET, Buenos Aires, C1425FQB, Argentina; Bioinnovo S.A, Buenos Aires, 1686, Argentina; CELINA G. VEGA, INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires, 1686, Argentina; CONICET, Buenos Aires, C1425FQB, Argentina; Bioinnovo S.A, Buenos Aires, 1686, Argentina; MATÍAS CASTELLS BAUER, INIA (Instituto Nacional de Investigación Agropecuaria), Uruguay; Molecular Virology Laboratory, CENUR North Litoral, Salto University Centre, University of the Republic, Salto, 50000, Uruguay; RODNEY COLINA, INIA (Instituto Nacional de Investigación Agropecuaria), Uruguay; Molecular Virology Laboratory, CENUR North Litoral, Salto University Centre, University of the Republic, Salto, 50000, Uruguay; ANDRÉS WIGDOROVITZ, INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires, 1686, Argentina; CONICET, Buenos Aires, C1425FQB, Argentina; Bioinnovo S.A, Buenos Aires, 1686, Argentina; VIVIANA PARREÑO, INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires, 1686, Argentina; CONICET, Buenos Aires, C1425FQB, Argentina; Bioinnovo S.A, Buenos Aires, 1686, Argentina. |
Título : |
Development of an IgY-based treatment to control bovine coronavirus diarrhea in dairy calves. |
Fecha de publicación : |
2023 |
Fuente / Imprenta : |
Viruses, 2023, volume 15, issue 3, article 708. OPEN ACCESS. doi: https://doi.org/10.3390/v15030708 |
ISSN : |
1999-4915 |
DOI : |
10.3390/v15030708 |
Idioma : |
Inglés |
Notas : |
Article history: Received 6 February 2023; Revised 5 March 2023; Accepted 6 March 2023; Published 9 March 2023. -- Academic Editor: Tomomi Takano. -- Correspondence author: Bok, M.; INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires 1686, Argentina; email:bok.marina@inta.gob.ar ; Parreño, V.; INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires, Argentina; email:parreno.viviana@inta.gob.ar -- This article belongs to the Special Issue Animal Coronaviruses: Infection, Prevention, and Antivirals https://www.mdpi.com/journal/viruses/special_issues/5XDFOYZ724 ) -- Funding: This work was supported by The National Institute of Agricultural Technology (INTA), ANPCyT from the Argentinean Agricultural Ministry (PICT Start Up 2010-1532), and Vetanco S.A. (CVT 20794). -- |
Contenido : |
Bovine Coronavirus (BCoV) is a major pathogen associated with neonatal calf diarrhea. Standard practice dictates that to prevent BCoV diarrhea, dams should be immunized in the last stage of pregnancy to increase BCoV-specific antibody (Ab) titers in serum and colostrum. For the prevention to be effective, calves need to suck maternal colostrum within the first six to twelve hours of life before gut closure to ensure a good level of passive immunity. The high rate of maternal Ab transfer failure resulting from this process posed the need to develop alternative local passive immunity strategies to strengthen the prevention and treatment of BCoV diarrhea. Immunoglobulin Y technology represents a promising tool to address this gap. In this study, 200 laying hens were immunized with BCoV to obtain spray-dried egg powder enriched in specific IgY Abs to BCoV on a large production scale. To ensure batch-to-batch product consistency, a potency assay was statistically validated. With a sample size of 241, the BCoV-specific IgY ELISA showed a sensitivity and specificity of 97.7% and 98.2%, respectively. ELISA IgY Abs to BCoV correlated with virus-neutralizing Ab titers (Pearson correlation, R2 = 0.92, p < 0.001). Most importantly, a pilot efficacy study in newborn calves showed a significant delay and shorter duration of BCoV-associated diarrhea and shedding in IgY-treated colostrum-deprived calves. Calves were treated with milk supplemented with egg powder (final IgY Ab titer to BCoV ELISA = 512; VN = 32) for 14 days as a passive treatment before a challenge with BCoV and were compared to calves fed milk with no supplementation. This is the first study with proof of efficacy of a product based on egg powder manufactured at a scale that successfully prevents BCoV-associated neonatal calf diarrhea. © 2023 by the authors. MenosBovine Coronavirus (BCoV) is a major pathogen associated with neonatal calf diarrhea. Standard practice dictates that to prevent BCoV diarrhea, dams should be immunized in the last stage of pregnancy to increase BCoV-specific antibody (Ab) titers in serum and colostrum. For the prevention to be effective, calves need to suck maternal colostrum within the first six to twelve hours of life before gut closure to ensure a good level of passive immunity. The high rate of maternal Ab transfer failure resulting from this process posed the need to develop alternative local passive immunity strategies to strengthen the prevention and treatment of BCoV diarrhea. Immunoglobulin Y technology represents a promising tool to address this gap. In this study, 200 laying hens were immunized with BCoV to obtain spray-dried egg powder enriched in specific IgY Abs to BCoV on a large production scale. To ensure batch-to-batch product consistency, a potency assay was statistically validated. With a sample size of 241, the BCoV-specific IgY ELISA showed a sensitivity and specificity of 97.7% and 98.2%, respectively. ELISA IgY Abs to BCoV correlated with virus-neutralizing Ab titers (Pearson correlation, R2 = 0.92, p < 0.001). Most importantly, a pilot efficacy study in newborn calves showed a significant delay and shorter duration of BCoV-associated diarrhea and shedding in IgY-treated colostrum-deprived calves. Calves were treated with milk supplemented with egg powder (final IgY Ab titer to BCoV ... Presentar Todo |
Palabras claves : |
Bovine coronavirus; Development; ELISA validation; IgY antibodies; Neonatal calf diarrhea. |
Asunto categoría : |
L20 Ecología animal |
URL : |
https://www.mdpi.com/1999-4915/15/3/708/pdf
|
Marc : |
LEADER 03567naa a2200277 a 4500 001 1064043 005 2023-04-19 008 2023 bl uuuu u00u1 u #d 022 $a1999-4915 024 7 $a10.3390/v15030708$2DOI 100 1 $aBOK, M. 245 $aDevelopment of an IgY-based treatment to control bovine coronavirus diarrhea in dairy calves.$h[electronic resource] 260 $c2023 500 $aArticle history: Received 6 February 2023; Revised 5 March 2023; Accepted 6 March 2023; Published 9 March 2023. -- Academic Editor: Tomomi Takano. -- Correspondence author: Bok, M.; INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires 1686, Argentina; email:bok.marina@inta.gob.ar ; Parreño, V.; INCUINTA, Virology Institute and Technology Innovations, National Institute of Agricultural Technology, Buenos Aires, Argentina; email:parreno.viviana@inta.gob.ar -- This article belongs to the Special Issue Animal Coronaviruses: Infection, Prevention, and Antivirals https://www.mdpi.com/journal/viruses/special_issues/5XDFOYZ724 ) -- Funding: This work was supported by The National Institute of Agricultural Technology (INTA), ANPCyT from the Argentinean Agricultural Ministry (PICT Start Up 2010-1532), and Vetanco S.A. (CVT 20794). -- 520 $aBovine Coronavirus (BCoV) is a major pathogen associated with neonatal calf diarrhea. Standard practice dictates that to prevent BCoV diarrhea, dams should be immunized in the last stage of pregnancy to increase BCoV-specific antibody (Ab) titers in serum and colostrum. For the prevention to be effective, calves need to suck maternal colostrum within the first six to twelve hours of life before gut closure to ensure a good level of passive immunity. The high rate of maternal Ab transfer failure resulting from this process posed the need to develop alternative local passive immunity strategies to strengthen the prevention and treatment of BCoV diarrhea. Immunoglobulin Y technology represents a promising tool to address this gap. In this study, 200 laying hens were immunized with BCoV to obtain spray-dried egg powder enriched in specific IgY Abs to BCoV on a large production scale. To ensure batch-to-batch product consistency, a potency assay was statistically validated. With a sample size of 241, the BCoV-specific IgY ELISA showed a sensitivity and specificity of 97.7% and 98.2%, respectively. ELISA IgY Abs to BCoV correlated with virus-neutralizing Ab titers (Pearson correlation, R2 = 0.92, p < 0.001). Most importantly, a pilot efficacy study in newborn calves showed a significant delay and shorter duration of BCoV-associated diarrhea and shedding in IgY-treated colostrum-deprived calves. Calves were treated with milk supplemented with egg powder (final IgY Ab titer to BCoV ELISA = 512; VN = 32) for 14 days as a passive treatment before a challenge with BCoV and were compared to calves fed milk with no supplementation. This is the first study with proof of efficacy of a product based on egg powder manufactured at a scale that successfully prevents BCoV-associated neonatal calf diarrhea. © 2023 by the authors. 653 $aBovine coronavirus 653 $aDevelopment 653 $aELISA validation 653 $aIgY antibodies 653 $aNeonatal calf diarrhea 700 1 $aVEGA, C.G. 700 1 $aCASTELLS, M. 700 1 $aCOLINA, R. 700 1 $aWIGDOROVITZ, A. 700 1 $aPARREÑO, V. 773 $tViruses, 2023, volume 15, issue 3, article 708. OPEN ACCESS. doi: https://doi.org/10.3390/v15030708
Descargar
Esconder MarcPresentar Marc Completo |
Registro original : |
INIA Las Brujas (LB) |
|
Biblioteca
|
Identificación
|
Origen
|
Tipo / Formato
|
Clasificación
|
Cutter
|
Registro
|
Volumen
|
Estado
|
Volver
|
Expresión de búsqueda válido. Check! |
|
|